BANK OF AMERICA CORP /DE/
BankPosition in HALO — Halozyme Therapeutics, Inc.
CIK 70858
CHARLOTTE, NC
Position in HALO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$214,503,706
+$26,229,474 QoQ
Shares Held
2,740,561
-5.9% QoQ
Ownership
2.41%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#8
of 667 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 74%
Shared 0%
None 26%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Derivatives in HALO
reported options exposure · as of Dec 31, 2022CallValue
$7,243,370
CallShares
127,300
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. HALO ranks #9 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in HALO
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $214,503,706 | 2,740,561 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $188,274,232 | 2,913,109 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $183,986,890 | 2,733,832 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $144,933,478 | 1,976,186 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $107,572,726 | 2,067,911 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $147,660,292 | 2,314,062 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $164,867,378 | 3,448,387 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $118,454,284 | 2,069,432 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $95,591,344 | 1,825,656 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $69,040,141 | 1,697,152 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $43,895,873 | 1,187,659 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $45,467,012 | 1,190,236 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $40,439,806 | 1,121,148 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $57,153,471 | 1,496,556 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $7,243,370 | 127,300 | Call | Defined | 2023-02-10 | |
| 2022-12-31 | $61,088,236 | 1,073,607 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $44,662,166 | 1,129,544 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $33,199,100 | 754,525 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $29,042,687 | 728,252 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $26,291,586 | 653,857 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $29,806,153 | 732,698 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $30,681,173 | 675,648 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $36,035,540 | 864,369 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $20,868,487 | 488,609 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $9,736,973 | 370,509 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $3,590,124 | 133,910 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $2,616,606 | 145,448 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||